<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Early repolarization</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Early repolarization</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Early repolarization</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Krahn, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Manoj Obeyesekere, MBBS, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark S Link, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 16, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H24315018"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The term early repolarization (ER), also known as "J waves" or "J-point elevation," has long been used to characterize a QRS-T variant on the electrocardiogram (ECG). Most literature defines ER as being present on the ECG when there is J-point elevation of ≥0.1 mV in two adjacent leads with either a slurred or notched morphology. Historically, ER has been considered a marker of good health because it is more prevalent in athletes, younger persons, and at slower heart rates. However, contemporary reports, largely based on data from resuscitated sudden cardiac arrest (SCA) patients, suggest an association between ER and an increased risk for arrhythmic death and idiopathic ventricular fibrillation (VF).</p><p>While some level of increased risk of sudden cardiac death (SCD) has been reported in persons with ER, the relatively high prevalence of the ER pattern in the general population (5 to 13 percent) in comparison with the incidence of idiopathic VF (approximately 10 cases per 100,000 population) means that the ER pattern will nearly always be an incidental ECG finding with no clinical implications. However, a primary arrhythmic disorder such as idiopathic VF due to ER is far more likely when associated with resuscitated SCD in the absence of other etiologies. (See <a class="local">'ER syndrome'</a> below.)</p><p>This topic will review the genetics, prevalence, clinical manifestations, and diagnosis of ER and will present an approach to the management of patients with ER and idiopathic VF.</p><p class="headingAnchor" id="H21542558"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>The definition of ER on an ECG is based on well-defined ECG findings  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. Although the 2013 Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society presented a definition  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>), the 2016 American Heart Association (AHA) Scientific Statement [<a href="#rid2">2</a>] highlights the lack of agreement across published studies pertaining to definition. A 2015 consensus document suggested reporting more detailed amplitudes of the J-wave including amplitudes corresponding to J-wave onset (Jo), J-wave peak (Jp), and J-wave termination (Jt), as well as durations D1 (Jo to Jp) and D2 (Jp to Jt), in relation to an end-QRS notch, and of Jp, Jt, and D2, in relation to an end-QRS slur [<a href="#rid3">3</a>]. The majority of publications at the present time merely adopt the amplitude of Jp as the reference point for measuring J-point elevation. The ST segment should be regarded as horizontal or downward sloping if the amplitude of the ST-segment 100 ms after the Jt (interval M) is equal to or less than the amplitude at Jt. The ST segment should be regarded as upward sloping if the amplitude of the ST segment 100 ms after Jt (interval M) is greater than the amplitude at Jt. However, duration measurements K, L, and M, each 100 ms, from Jo, Jp and Jt could be used in the measurement of the ST slope in the presence of a notch or duration measurements L or M, each 100 ms, used in the presence of an end-QRS slur with onset from Jp or Jt to measure slope, respectively  (<a class="graphic graphic_figure graphicRef118056" href="/d/graphic/118056.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H21543526"><span class="h2">ECG findings</span><span class="headingEndMark"> — </span>On the ECG, ER is defined as either:</p><p class="bulletIndent1"><span class="glyph">●</span>A sharp well-defined positive deflection or notch immediately following a positive QRS complex at the onset of the ST segment; correspondingly, in negative QRS complexes, J waves may also be negative.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of slurring at the terminal part of the QRS complex (since the J-wave or J-point elevation may be hidden in the terminal part of the QRS complex, resulting in the slurring of the terminal QRS complex)  (<a class="graphic graphic_waveform graphicRef83883" href="/d/graphic/83883.html" rel="external">waveform 1</a>).</p><p></p><p>Most literature defines ER as being present on the ECG when there is J-point elevation of ≥0.1 mV in two adjacent leads with either a slurred or notched morphology [<a href="#rid2">2,4,5</a>]. The AHA scientific statement proposed the use of ER qualified with descriptive terms such as with ST-segment elevation, the magnitude, ER with terminal slur/notch and also noting the distribution on the ECG and any concomitant ECG findings (eg, J-wave augmentation or short coupled ventricular ectopy).</p><p class="headingAnchor" id="H21543262"><span class="h2">ECG classification</span><span class="headingEndMark"> — </span>Based on data associating arrhythmic risk with spatial distribution of ER, a classification scheme has been proposed [<a href="#rid6">6,7</a>] (see <a class="local">'Prognosis of ER pattern'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Type 1 is associated with ER in the lateral precordial leads. This form is common among healthy male athletes and is thought to be largely benign.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 2 is associated with ER in the inferior or inferolateral leads and is associated with a moderate level of risk.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 3 is associated with ER globally in the inferior, lateral, and right precordial leads, and appears to be associated with the highest relative risk, though the absolute risk of sudden death remains small [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 4, or Brugada syndrome, is marked by J-wave/point elevation in the right precordial leads. (See  <a class="medical medical_review" href="/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>.)</p><p></p><p>While this classification system would seem to simplify categorization of the ECG patterns, it has been criticized due to the controversial presumed common pathophysiological substrate across the four types [<a href="#rid9">9,10</a>].</p><p class="headingAnchor" id="H21543378"><span class="h2">Concealed ER</span><span class="headingEndMark"> — </span>The ER pattern is not always identified on routine ECG due to the intermittent nature of ER [<a href="#rid11">11</a>]. As an example, among 542 persons with baseline ER who underwent repeat ECG examination five years later, ER (≥0.1 mV) was not observed in approximately 20 percent [<a href="#rid5">5</a>]. No systematic evaluation has been undertaken reporting the prevalence of concealed ER in the general population, and the clinical importance, if any, of concealed ER remains unclear.</p><p class="headingAnchor" id="H21543506"><span class="h2">ER pattern versus ER syndrome</span><span class="headingEndMark"> — </span>As noted above, ER is an ECG finding. Two terms, distinguished by the presence or absence of symptomatic arrhythmias, have been used to describe patients with this ECG finding:</p><p class="bulletIndent1"><span class="glyph">●</span>The ER <strong>pattern</strong> describes the patient with appropriate ECG findings in the absence of symptomatic arrhythmias.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ER <strong>syndrome</strong> applies to the patient with both appropriate ECG findings and symptomatic arrhythmias.</p><p></p><p>Persons with either the ER pattern or ER syndrome can have identical findings on surface ECG. However, the mere presence of ER pattern on ECG should not lead to a classification of ER syndrome in the absence of symptoms or documented ventricular fibrillation (VF) [<a href="#rid12">12</a>].</p><p>Rarely, ER may be associated with the primary arrhythmic disorder idiopathic VF in the absence of structural heart disease [<a href="#rid4">4,11</a>]. Given the prevalence of ER pattern in the general population and the exceedingly low incidence of idiopathic VF, the diagnosis of idiopathic VF due to malignant ER is a diagnosis of exclusion. (See <a class="local">'ER syndrome'</a> below.)</p><p class="headingAnchor" id="H21543802"><span class="h1">PREVALENCE OF ER AND INCIDENCE OF IDIOPATHIC VF</span></p><p class="headingAnchor" id="H21543845"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Several population studies have estimated that the prevalence of ER ranges from 5 to 18 percent of persons, with higher prevalence in younger patients [<a href="#rid5">5,13-15</a>]. In a multiethnic population, ER pattern was independently associated with greater LV mass [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H21543852"><span class="h2">Arrhythmic risk</span><span class="headingEndMark"> — </span>The perception that ER was a benign finding devoid of clinical significance changed as case reports, case-control studies, and population studies established a link between the presence of ER and an increased risk for arrhythmic death, in particular idiopathic ventricular fibrillation (VF) [<a href="#rid4">4,5,8,13-15,17-23</a>].</p><p>Even though ER is fairly common in the general population, idiopathic VF is rare. In one report which estimated the incidence of idiopathic VF, the estimated risk of developing idiopathic VF in an individual younger than 45 years was 3 in 100,000 [<a href="#rid13">13,24</a>]. The risk increased to 11 in 100,000 when J waves  (<a class="graphic graphic_waveform graphicRef56369" href="/d/graphic/56369.html" rel="external">waveform 2</a>) were present. Although ER increased the relative risk of SCD, the absolute risk was very low. In a meta-analysis, the relative risk of arrhythmic death in persons with the ER pattern was 1.70 (95% CI 1.19-2.42), and the estimated absolute risk for arrhythmic death was 70 per 100,000 person-years [<a href="#rid25">25</a>]. Therefore, the incidental identification of ER should not be interpreted as a high-risk marker for arrhythmic death due to the relatively low odds of SCD based on ER alone.</p><p class="headingAnchor" id="H21543859"><span class="h2">Athletes with early repolarization</span><span class="headingEndMark"> — </span>The prevalence of J-point elevation among 121 young athletes was reported at 22 percent, a prevalence rate higher than seen in the general population [<a href="#rid13">13</a>]. However, higher ER prevalence rates ranging as high as 44 percent have also been reported in athletes [<a href="#rid26">26,27</a>].</p><p>The reported higher prevalence of ER in athletes likely is related to the physiological balance in autonomic tone favoring the parasympathetic tone and its regulation of the action potential [<a href="#rid28">28</a>].</p><p>Notably, the association of ER with arrhythmic risk is typically at rest or during sleep and not during physical activity when J-point elevation is typically markedly reduced or eliminated. In a study of 704 athletes (14 percent with ER) with six years follow-up, there were no arrhythmic events [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H4191980"><span class="h1">PROGNOSIS OF ER PATTERN</span><span class="headingEndMark"> — </span>Certain ECG characteristics may distinguish the benign ER pattern from patterns associated with an arrhythmic prognosis. Additionally, ER pattern may be modified by physiological variables with subsequent effect on prognosis. The coexistence of ER with other cardiac pathologies also likely influences prognosis/arrhythmic risk. Reports suggest that ER may be viewed as an adjunctive prognostic variable in the presence of other cardiac pathologies (ie, ER may incrementally worsen the prognosis of other more common conditions such as ischemic heart disease).</p><p class="headingAnchor" id="H439497692"><span class="h2">Prognosis in the general population</span><span class="headingEndMark"> — </span>While the ER pattern is associated with an increased relative risk of adverse events, the prognostic implications described in this section should be viewed in the context of the <strong>overall very low risk of SCD</strong> in those with this asymptomatic ECG finding. Thus, even with a twofold increase in relative risk of SCD, the absolute risk remains exceedingly low. Additionally, in spite of the data discussed in this section, there is no current risk stratification strategy for asymptomatic patients with ER pattern in the general population and within families with ER pattern that would allow for the identification of higher risk individuals with the ER pattern who might be candidates for treatment. (See <a class="local">'Prevalence'</a> above and <a class="local">'Arrhythmic risk'</a> above and <a class="local">'Treatment of ER pattern'</a> below.)</p><p>The presence of the ER pattern has generally been associated with adverse outcomes in numerous cohort and case-control studies, although some studies have suggested no overall impact on mortality after adjusting for comorbidities including coronary risk factors [<a href="#rid4">4,5,13-15,17,25,30-33</a>].</p><p class="headingAnchor" id="H4192086"><span class="h2">Prognostic variables</span><span class="headingEndMark"> — </span>Variables thought to affect prognosis that have been investigated include:</p><p class="bulletIndent1"><span class="glyph">●</span>Distribution and amplitude of ER</p><p class="bulletIndent1"><span class="glyph">●</span>Morphology of the J wave, ST segment, T wave, T<sub>peak</sub> - T<sub>end</sub> interval</p><p class="bulletIndent1"><span class="glyph">●</span>Age and sex</p><p class="bulletIndent1"><span class="glyph">●</span>Family history</p><p class="bulletIndent1"><span class="glyph">●</span>Slurring versus notching</p><p class="bulletIndent1"><span class="glyph">●</span>Ethnicity</p><p class="bulletIndent1"><span class="glyph">●</span>Association with other cardiac pathology</p><p></p><p class="headingAnchor" id="H4192118"><span class="h3">Distribution and amplitude of early repolarization</span><span class="headingEndMark"> — </span>The inferior location of ER, in addition to higher J-point amplitude, have been described as variables associated with increased arrhythmic risk in both the general population and in patients with idiopathic ventricular fibrillation (VF), although some conflicting data have been reported in the general population.</p><p class="bulletIndent1"><span class="glyph">●</span>J-point elevation greater than 0.1 mV in the inferior leads in the large Finnish cohort study of 10,864 persons was weakly associated with an increased risk for death from cardiac causes (adjusted RR 1.28, 95% CI 1.04-1.59) [<a href="#rid5">5</a>]. While observed in only 0.3 percent of the cohort, J-point elevation greater than 0.2 mV in inferior leads  (<a class="graphic graphic_waveform graphicRef83891" href="/d/graphic/83891.html" rel="external">waveform 3</a>) was associated with a three times greater risk of death from cardiac causes (adjusted RR 2.98, 95% CI 1.85-4.92) [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a population-based case-cohort study of 6213 persons (1945 persons with ECGs) with a mean follow-up of 19 years, ER was associated with higher cardiac mortality (hazard ratio 1.96, 95% CI 1.05-3.68) [<a href="#rid14">14</a>]. An inferior localization of ER further increased ER-attributable cardiac mortality (hazard ratio 3.15, 95% CI 1.58-6.28. However, these findings were not replicated in a cohort of 20,661 patients (90.5 percent male) with a median follow-up of 17.5 years, among whom the findings of ER were not associated with an increased risk of cardiovascular death [<a href="#rid34">34</a>].</p><p></p><p class="headingAnchor" id="H762731453"><span class="h3">Morphology of the ST segment</span><span class="headingEndMark"> — </span>The morphology of the ST segment may also determine the risk associated with ER, with a horizontal or downsloping ST segment following ER portending a higher risk in both the general population and in patients with idiopathic VF [<a href="#rid24">24,26,31</a>]. However, despite the increased risk of arrhythmia associated with the horizontal/downsloping ER pattern, the prevalence of this pattern in controls (approximately 3 percent) compared with the exceedingly low incidence of idiopathic VF renders this variable alone devoid of meaningful test accuracy [<a href="#rid24">24,26</a>]. In one study that compared 92 patients with ER and VF with 247 control patients with asymptomatic ER pattern, patients with ER and VF had a higher prevalence of low-amplitude T waves, lower T/R ratio (lead II or V5), and longer QTc interval [<a href="#rid35">35</a>]. The authors suggested the combination of these parameters with J-wave amplitude and distribution of J waves may further allow for improved identification of malignant ER.</p><p>T<sub>peak</sub> to T<sub>end</sub> interval has been reported to predict malignant ventricular arrhythmias in an ER syndrome model [<a href="#rid36">36</a>]<strong>, which is prolonged in patients with VF attributed to ER syndrome (</strong>86.7 ± 14 ms versus 68 ± 13.2 ms, p&lt;0.001<strong>) </strong>[<a href="#rid37">37</a>]<strong>.</strong></p><p>J-wave duration (interval from Jo and the intersection of the tangent to the J wave with the isoelectric line &gt;60 ms) and slope/j-angle (angle between an ideal line drawn from Jo perpendicular to the isoelectric line and the tangent to the J wave &gt;30°) have been reported to identify the malignant form of ER from the benign form [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H4192132"><span class="h3">Age and sex</span><span class="headingEndMark"> — </span>Although the data are conflicting, males with ER in the inferior leads may be at greater risk of cardiac mortality than males without ER or females with or without ER [<a href="#rid14">14</a>]. However in a conflicting study reporting on 6631 Finnish general population subjects (age ≥30 years) with ER (≥0.1 mV in ≥2 inferior/lateral leads),<strong> </strong>ER was associated with SCD in subjects younger than 50 years, particularly in women, but not in subjects 50 years and older [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H4192139"><span class="h3">Family history</span><span class="headingEndMark"> — </span>Conflicting data exist regarding the prognostic significance of a family history of SCD in persons with ER, such that no clear recommendations regarding risk assessment or treatment can be made [<a href="#rid4">4,40</a>]. Further studies are required to define the risk contribution of a family history of SCD to the prognosis of a patient with ER since no clear mechanism for inheritance of risk has been identified. Society guidelines support a possible role for an implantable cardioverter-defibrillator (ICD) in symptomatic family members of ER syndrome patients with a history of syncope in the presence of ST-segment elevation, or asymptomatic individuals with a high-risk ER pattern in the presence of a family history of early sudden death. The latter should be exceptional, in discussion with an expert versed in assessment of familial sudden death syndromes [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H4192170"><span class="h3">Slurring versus notching</span><span class="headingEndMark"> — </span>Although both slurring and notching type ER are observed and may exist in the same patient, the prognostic value of one compared with the other has not been clearly established  (<a class="graphic graphic_waveform graphicRef83883" href="/d/graphic/83883.html" rel="external">waveform 1</a> and <a class="graphic graphic_figure graphicRef83884" href="/d/graphic/83884.html" rel="external">figure 2</a>) [<a href="#rid11">11,15,24,31,34,42</a>]. However, a meta-analysis of 19 observational studies (7268 patients with 1127 cases of ventricular arrhythmias or SCD) demonstrated a higher risk with J waves in the inferior leads, with notching, and horizontal or descending ST segment [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H4192178"><span class="h3">Ethnicity</span><span class="headingEndMark"> — </span>Although ER pattern is more common in African Americans [<a href="#rid44">44</a>], there is no clear attributable risk associated with ethnicity, and African Americans are not specifically over represented in idiopathic VF cohorts compared with White Americans [<a href="#rid45">45</a>]. Thus, no clinically relevant risk stratification can be undertaken to identify the small subset at high risk for primary prevention.</p><p class="headingAnchor" id="H4192185"><span class="h3">Modifying risk of underlying cardiac pathology</span><span class="headingEndMark"> — </span>In the context of structural heart disease or primary electrical disorders, the ER pattern may be a modifier of underlying arrhythmic risk associated with heterogeneous cardiac conditions (myocardial infarction [<a href="#rid46">46,47</a>], coronary disease [<a href="#rid48">48</a>], heart failure [<a href="#rid49">49</a>], SQTS [<a href="#rid50">50,51</a>], LVNC [<a href="#rid52">52</a>], LQTS [<a href="#rid53">53,54</a>], CPVT [<a href="#rid55">55</a>], Brugada [<a href="#rid56">56</a>]), in addition to the rare association with idiopathic VF (ie, in the absence of other cardiac conditions).</p><p>Thus, the ER pattern is potentially a marker for increased arrhythmic mortality due to a vulnerable repolarization substrate when combined across a number of heterogeneous clinical conditions (eg, short QT syndrome, Brugada syndrome, or ischemic heart disease) in the general population, in addition to rarely being a primary arrhythmogenic disorder.</p><p>Early repolarization may also indicate an underlying atrial electrical substrate for atrial fibrillation; however, studies are conflicting [<a href="#rid57">57,58</a>].</p><p class="headingAnchor" id="H524966104"><span class="h2">Risk stratification with invasive EP studies</span><span class="headingEndMark"> — </span>Invasive electrophysiologic studies (EPS) do not appear to improve the risk stratification of patients with the ER syndrome and prior VF arrest [<a href="#rid59">59</a>]. (See <a class="local">'Chronic treatment of ER syndrome'</a> below and  <a class="medical medical_review" href="/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p class="headingAnchor" id="H24315026"><span class="h1">GENETIC BASIS AND INHERITANCE OF ER</span><span class="headingEndMark"> — </span>The genetic basis of ER syndrome continues to be elucidated, with the evidence restricted to either case reports or preliminary studies that have not identified an accepted genetic basis of ER [<a href="#rid60">60,61</a>]. The reported implicated gene mutations involve the <em>KCNJ8</em> gene (responsible for the ATP-sensitive potassium channel Kir6.1 - I<sub>KATP</sub> current); <em>CACNA1C</em>, <em>CACNB2</em>, <em>CACNA2D1</em> genes (responsible for the cardiac L-type calcium channel - I<sub>Ca.L</sub> current); and the <em>SCN5A</em> gene (responsible for the sodium channel - I<sub>Na</sub> current)  (<a class="graphic graphic_figure graphicRef70771" href="/d/graphic/70771.html" rel="external">figure 3</a>) [<a href="#rid60">60-64</a>]. First-degree relatives of patients with the ER pattern are more likely to also demonstrate the pattern, but this weak association has not been associated with clinical implications [<a href="#rid65">65,66</a>].</p><p class="headingAnchor" id="H3247895691"><span class="h2">Inheritance of ER pattern</span><span class="headingEndMark"> — </span>The ER pattern may be sporadic or inherited, although first-degree relatives of a person with the ER pattern appear to have a two to threefold higher likelihood of also having the ER pattern on ECG [<a href="#rid65">65,66</a>]. While the vast majority of ER is likely sporadic, familial ER appears to be transmitted in an autosomal dominant fashion [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H23509702"><span class="h2">Gain of function mutations</span><span class="headingEndMark"> — </span>Consistent with the reports that I<sub>KATP</sub> activation (<em>KCNJ8 and ABCC9</em>) or I<sub>to</sub> (<em>KCNE5</em> mutation and rare polymorphism in <em>DPP10</em>) can generate an ER pattern on the surface ECG, several investigators have detected a rare missense mutation, S422L in <em>KCNJ8</em>, to be associated with ER and idiopathic ventricular fibrillation (VF) [<a href="#rid60">60,62,63,68</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>The first report on this variant was a case report of a 14-year-old female who experienced numerous episodes of recurrent idiopathic VF unresponsive to beta-blockers, multiple anti-arrhythmic medications and <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> [<a href="#rid60">60</a>]. Recurrences of VF were associated with a marked accentuation of ER.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 87 patients with Brugada syndrome and 14 patients with ER syndrome, one Brugada syndrome case and one ER syndrome case hosted the identical missense mutation S422L. Investigators demonstrated that I<sub>KATP</sub> was increased significantly in the S422L variant compared with Kir6.1 wild type channels [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A separate study of 204 patients and family members with Brugada syndrome or ER syndrome also demonstrated a similar gain of function of the Kir6.1 channel (identified in three Brugada syndrome and one ER syndrome proband) [<a href="#rid63">63</a>].</p><p></p><p><em>KCNJ8-S422L</em> is highly conserved across species and was absent in the reference alleles in these three studies [<a href="#rid60">60,62,63</a>]. This gain of function variant appears to be pathogenic in ER and idiopathic VF.</p><p>Gain of function of I<sub>to</sub> by missense variant (c.2240T &gt; C/p. L747P) in <em>DPP6</em> in four families with SCA due to ER syndrome has been reported [<a href="#rid69">69</a>].</p><p>A heterozygous gain of function missense mutation in a highly conserved (K801T) residue in the hERG (<em>KCNH2</em> gene) in a single Chinese family with ER syndrome involving four nocturnal SCD events has been reported involving the proband with ER syndrome and affected family members and was not present in a control population of 150 individuals [<a href="#rid70">70</a>]. Whole-cell patch-clamp methods were used to characterize the gain of function.</p><p>A heterozygous gain of function mutation of KCND3 encoding Kv4.3, an α-subunit (I<sub>to</sub>), Gly306Ala (c.917g&gt;c) was reported to be associated with ER syndrome in a 12-year-old male SCA survivor [<a href="#rid71">71</a>].<sub> </sub><a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">Isoproterenol</a> and <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a> were effective in preventing VF recurrence with restoration of the J-point elevation. Furthermore, a genome wide association with ER on chromosome 1 in the <em>KCND3</em> gene with rs1545300 as the lead polymorphism has been reported [<a href="#rid72">72</a>]. A total <em>KCND3</em> duplication (with likely increase in I<sub>to </sub>current) has been reported in a patient with nonfatal nocturnal SCA and intermittent ER [<a href="#rid73">73</a>], responding to quinidine. Segregation analysis of available family members identified the proband's asymptomatic daughter as a carrier also demonstrating J-point elevation.</p><p class="headingAnchor" id="H23509793"><span class="h2">Loss of function mutations</span><span class="headingEndMark"> — </span>Loss of function mutations of the inward sodium channel gene and cardiac L-type calcium channel gene have also been implicated in patients with ER (<em>CACNA1C</em>, <em>CACNB2</em>, and <em>CACNA2D1</em> genes)  (<a class="graphic graphic_figure graphicRef70771" href="/d/graphic/70771.html" rel="external">figure 3</a>). Two small studies (three and four patients with ER, respectively) have reported that mutations in these highly conserved residues were associated with ER, suggesting linkage of these genes with ER [<a href="#rid61">61,64</a>].</p><p>The complex genetic basis continues to be explored. Highlighting the complexity, a study indicated that the c.4297 G&gt;C missense mutation in the <em>SCN5A</em> gene caused a "loss-of-function" of sodium channels accounting for the ER syndrome in a single case [<a href="#rid74">74</a>]. The reduction in INa density was due to a decreased number of sodium channels caused by abnormal translation processes. However, the synonymous <em>T5457C</em> polymorphism on the same allele partially restored the INa density of the mutant channels by the upregulation of mRNA levels. Furthermore, <em>KCNE1</em> (and others) may be modulatory genes associated to ER syndrome [<a href="#rid75">75</a>].</p><p>A genome-wide association study was not able to reliably identify genetic variants predisposing to ER, presumably due to insufficient statistical power and phenotype heterogeneity [<a href="#rid76">76</a>]. This does however suggest that the genetic mechanisms may be multifactorial and that an ER gene or family of genes is an unlikely outcome of further ascertainment. Furthermore, a small proportion of reported genetic variants have undergone functional studies, and none has been studied in genetically engineered animal models. The poverty of validation of mutation effects remains a significant limitation when interpreting genetic test results.</p><p class="headingAnchor" id="H24316804"><span class="h1">MECHANISM OF ER AND IDIOPATHIC VENTRICULAR FIBRILLATION</span><span class="headingEndMark"> — </span>There is controversy regarding whether the ER pattern represents abnormal repolarization or depolarization.</p><p class="bulletIndent1"><span class="glyph">●</span>The repolarization theory is based on the presence of a prominent action potential notch in the epicardium but not endocardium, which has been demonstrated to result in a voltage gradient that manifests as ER on the ECG  (<a class="graphic graphic_figure graphicRef70771" href="/d/graphic/70771.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef83884" href="/d/graphic/83884.html" rel="external">figure 2</a>) [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The depolarization theory is based on epicardial structural elements with conduction disturbances/delays in the epicardium [<a href="#rid78">78-80</a>]. The cause for this abnormal conduction leading to delayed and fractionated local epicardial electrograms remains unknown. A repolarization disparity secondary to the depolarization abnormality may also accentuate this mechanism.</p><p></p><p>It is more likely that two mechanisms are contributing to ER. Clinical mapping data suggest two distinct substrates, delayed depolarization (with evident delayed local epicardial electrograms) and early repolarization abnormality (with absence of local delayed electrograms), underlie the J wave [<a href="#rid78">78,79</a>]. The term "J-wave syndromes" has been proposed in light of the heterogenous mechanisms to eliminate the implied mechanism in the term ER.</p><p>Clinical studies also suggest the likelihood of two different substrates:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 206 persons with idiopathic VF and the ER pattern, only a minority of cases (11 percent) had late potentials on signal-averaged ECG, with a prevalence similar to the control group who did not have the ER pattern (13 percent), suggesting that ER is not a depolarization phenomenon  (<a class="graphic graphic_figure graphicRef83890" href="/d/graphic/83890.html" rel="external">figure 4</a>) [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, in a smaller study of 22 patients with apparently idiopathic VF who were monitored using a signal-averaging system to record depolarization markers, repolarization markers, and autonomic modulation, the incidence of late potentials in persons with VF was significantly higher in those with the ER pattern (86 versus 27 percent in those without ER pattern) [<a href="#rid18">18</a>]. In contrast, repolarization markers did not differ between the two groups. These investigators concluded that ER might be more closely associated with a depolarization abnormality and autonomic modulation than with repolarization.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Given that the mechanism for ER is likely heterogenous, the precise mechanism for ER-related idiopathic ventricular fibrillation (VF) is also likely heterogenous. The repolarization theory holds to endo-epicardial action potential gradients caused by gain or loss of function mutations by outward or inward currents respectively, causing phase 2 reentry and polymorphic VT/VF [<a href="#rid81">81</a>]. The depolarization theory holds to unidentified micro-structural abnormalities in the right ventricular (RV) epicardium, causing conduction delay and local triggers and reentry [<a href="#rid78">78</a>].</p><p></p><p>The two different mechanisms will likely have implications for therapy, with varied response to pharmacotherapy. The response to <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> has been reported to be variable, with inferior J waves persisting in 35 percent, suggestive of a depolarization substrate, and normalizing (or decreasing) in 65 percent, suggestive of an early repolarization substrate [<a href="#rid82">82</a>]. <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">Quinidine</a> and isoproterenol have been demonstrated to restore electrical homogeneity by restoring the epicardial action potential dome, thus preventing VT/VF [<a href="#rid82">82</a>]. In contrast, those who fail to respond to quinidine tend to display depolarization abnormalities [<a href="#rid78">78</a>].</p><p>Furthermore, late depolarization may be associated with gene variants in the Na channel, connexins, and structural proteins, whereas mutations in I<sub>to</sub>, IK-ATP, or ICa may be associated with early repolarization [<a href="#rid79">79</a>]. Sodium channel blockers have been demonstrated to accentuate the ER in those with depolarization substrates and not in those devoid of depolarization substrate, further highlighting the heterogenous mechanism [<a href="#rid78">78</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>ER mechanistically demonstrates some similarities to Brugada syndrome and short QT syndrome (SQTS). (See  <a class="medical medical_review" href="/d/html/16697.html" rel="external">"Short QT syndrome"</a> and  <a class="medical medical_review" href="/d/html/1020.html" rel="external">"Brugada syndrome: Epidemiology and pathogenesis", section on 'Pathogenesis'</a>.)</p><p></p><p class="headingAnchor" id="H24316862"><span class="h1">CLINICAL MANIFESTATIONS AND DIAGNOSIS</span></p><p class="headingAnchor" id="H594480"><span class="h2">ER pattern</span><span class="headingEndMark"> — </span>Given the relatively high prevalence of the ER pattern in the general population (5 to 13 percent) in comparison with the incidence of idiopathic ventricular fibrillation (VF) (approximately 10 cases per 100,000 population), the ER pattern is nearly always a benign incidental ECG finding. There are no specific signs or symptoms attributed to the ER pattern. In the absence of SCA, no additional testing is required in persons with the ER pattern.</p><p>Asking patients to perform the Valsalva maneuver may unmask or accentuate the ER pattern. While performing this maneuver has been shown to aid in the identification of the ER pattern in high-risk familial ER, this has not been validated, and its applicability to broad populations of asymptomatic persons has not been evaluated [<a href="#rid67">67</a>]. The Valsalva maneuver is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1034.html" rel="external">"Vagal maneuvers"</a>.)</p><p class="headingAnchor" id="H24316877"><span class="h2">ER syndrome</span><span class="headingEndMark"> — </span>Patients with ER syndrome typically present with SCA due to VF. Syncope has not been shown to be more common in patients with ER pattern [<a href="#rid65">65,83</a>].</p><p>The diagnosis of ER syndrome is most commonly considered in a survivor of SCD with ECG evidence of VF and an apparently structurally normal heart following extensive testing  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>). A systematic assessment of the survivors of SCD without evidence of infarction or left ventricular dysfunction is reported to establish a causative diagnosis in the majority of cases [<a href="#rid11">11,84</a>]. Systematic evaluation includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac monitoring.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signal-averaged ECG.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exercise testing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiogram.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac magnetic resonance imaging.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exclusion of coronary artery disease or anomalies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous sodium channel blocker challenge (discretionary epinephrine challenge).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Targeted genetic testing should also be considered when a heritable phenotype is suggested. (See  <a class="medical medical_review" href="/d/html/1053.html" rel="external">"Congenital long QT syndrome: Diagnosis"</a> and  <a class="medical medical_review" href="/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a> and  <a class="medical medical_review" href="/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>.)</p><p></p><p>In patients whose evaluation revealed no identifiable cardiac pathology, idiopathic VF and the ER syndrome should be considered. A careful review of all available ECGs for evidence of ER is warranted, particularly around the time of the cardiac arrest [<a href="#rid11">11</a>]. ECGs often show variable and at times absent ER, so thorough review is important. VF storms in the idiopathic VF patients attributed to ER syndrome were highly associated with J wave augmentation prior to the VF onset [<a href="#rid85">85</a>].</p><p>ER syndrome causing VF <strong>may be diagnosed</strong> when:</p><p class="bulletIndent1"><span class="glyph">●</span>Other etiologies have been systematically excluded</p><p class="bulletIndent1"><span class="glyph">●</span>When J-point elevation is augmented immediately preceding VF</p><p></p><p>ER syndrome causing VF <strong>is probable</strong> when:</p><p class="bulletIndent1"><span class="glyph">●</span>Other etiologies have been systematically excluded</p><p class="bulletIndent1"><span class="glyph">●</span>ER pattern exists or increased parasympathetic tone provokes ER</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac arrest occurs at rest or during sleep</p><p></p><p>These patients may also display a high-risk ER pattern (J-point elevation &gt;2 mm in the inferior or inferolateral leads or globally and/or horizontal or down sloping ST segment. (See <a class="local">'Prognosis of ER pattern'</a> above.)</p><p>The ER pattern is not always identified on routine ECG due to the intermittent nature of ER. Bradycardia dependent and vagally dependent augmentation of ER has been reported [<a href="#rid86">86</a>]. However, no provocative test, such as pharmacologic augmentation of parasympathetic tone, is currently available and validated in this setting. Although the utility has not been studied systematically, tilt table testing may be of assistance to establish if vagal stimulation is associated with VF/syncope and/or if high-risk ER features are provoked. However, the diagnostic accuracy of this approach is unknown, and vasovagal syncope is far more common in comparison with VF due to ER syndrome. (See <a class="local">'Prognostic variables'</a> above and  <a class="medical medical_review" href="/d/html/1016.html" rel="external">"Upright tilt table testing in the evaluation of syncope"</a>.)</p><p class="headingAnchor" id="H3161175"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H3161269"><span class="h2">ER versus Brugada syndrome</span><span class="headingEndMark"> — </span>Some individuals with Brugada syndrome (ECG findings of ST-segment elevation in leads V1 to V2 associated with SCD or sustained ventricular arrhythmia) also have ER (approximately 12 percent) as variants in genes encoding the L-type calcium channel, ATP-sensitive potassium channel, and sodium channels have been associated with both of these conditions [<a href="#rid61">61,62,64,87-90</a>]. Additionally, some ECG characteristics of ER resemble features of the Brugada ECG, including J waves, pause and bradycardia dependent accentuation, the dynamic nature of the ECG manifestations, short-coupled extra-systole-induced polymorphic ventricular tachycardia/ventricular fibrillation, and suppression of the ECG features and arrhythmia with <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> and <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a> [<a href="#rid8">8,82</a>].</p><p>However, the provocation of the Brugada pattern by sodium channel blocker is not observed in ER [<a href="#rid91">91</a>]. In fact, sodium channel blockers in most patients with ER attenuate the J-point, whereas the J-point is augmented by sodium-channel blockers in the right precordial leads in patients with a Brugada ECG. Furthermore, a positive signal-averaged ECG and structural abnormalities in the RV outflow tract are not consistently observed and have not been reported in patients with ER, respectively [<a href="#rid92">92-94</a>]. (See  <a class="medical medical_review" href="/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>.)</p><p class="headingAnchor" id="H21544950"><span class="h2">ER versus acute pericarditis</span><span class="headingEndMark"> — </span>As is seen in ER, there is J-point elevation with resultant ST segment elevation in patients with acute pericarditis. Symptom presentation is markedly different in the two conditions. Unlike ER, most patients with acute pericarditis have ST elevations diffusely in most or all limb and precordial leads. Additionally, patients with acute pericarditis often have deviation of the PR segment, which is not present in ER. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Electrocardiogram'</a>.)</p><p class="headingAnchor" id="H21544966"><span class="h2">ER versus acute myocardial injury</span><span class="headingEndMark"> — </span>While patients with acute myocardial injury due to ST-elevation myocardial infarction (STEMI) can initially have elevation of the J point with concave ST-segment elevation, the ST-segment elevation typically becomes more pronounced and convex (rounded upward) as the infarction persists. However, the primary distinguishing factor between ER and acute myocardial injury is the presence of clinical symptoms such as chest pain or dyspnea. The distinction between the ECG findings of ER and acute MI are discussed in greater detail elsewhere. (See  <a class="medical medical_review" href="/d/html/2095.html" rel="external">"Electrocardiogram in the diagnosis of myocardial ischemia and infarction", section on 'Early repolarization'</a>.)</p><p class="headingAnchor" id="H595923"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H595931"><span class="h2">Treatment of ER pattern</span><span class="headingEndMark"> — </span>As discussed above, the ER pattern is nearly always a benign incidental ECG finding, with no specific signs or symptoms attributed to it. In addition, there is no current risk stratification strategy for asymptomatic patients with ER pattern in the general population and within families with ER pattern that would allow for the identification of higher risk individuals with the ER pattern who might be candidates for treatment. The 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society guideline for management of patients with ventricular arrhythmias and the prevention of SCD recommends observation with no treatment, and the 2015 European Society of Cardiology guidelines on the treatment of ventricular arrhythmias and prevention of SCD found that there was "insufficient evidence" to make a recommendation on the management of the ER pattern without associated symptomatic ventricular arrhythmias [<a href="#rid12">12,95</a>].</p><p>As such, for patients with the incidental finding of the ER pattern on their ECG, we recommend observation without therapy  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H24316898"><span class="h2">Treatment of ER syndrome with idiopathic VF</span><span class="headingEndMark"> — </span>Among survivors of SCD due to idiopathic ventricular fibrillation (VF), the reported rate of recurrent VF ranges between 22 and 37 percent at two to four years [<a href="#rid96">96-98</a>]. Because these patients have no demonstrated structural heart disease, they have an excellent prognosis for long-term survival if VF is treated  (<a class="graphic graphic_algorithm graphicRef83895" href="/d/graphic/83895.html" rel="external">algorithm 1</a>). As a result, such patients are best treated with an ICD [<a href="#rid12">12,95-100</a>]. (See  <a class="medical medical_review" href="/d/html/946.html" rel="external">"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy"</a>.)</p><p>In patients with idiopathic VF, substrate and/or trigger ablation is feasible, safe, and effective in specialized centers [<a href="#rid78">78,79</a>]. In 43 patients undergoing ablation for recurrent VF episodes due to ER syndrome, two phenotypes were identified; one with late depolarization abnormalities predominantly in the epicardium of the RV outflow tract and RV inferolateral epicardium (group 1), and the other with VF triggers associated with Purkinje sites but <strong>without</strong> abnormal epicardial/endocardial depolarization substrates (group 2) [<a href="#rid78">78</a>]. Epicardial anterior RV, RV outflow tract, inferior RV, posterior and posterolateral LV and apical ablation guided by location of abnormal depolarization substrates +/- premature ventricular complex/contraction (PVC; also referred to a premature ventricular beats or premature ventricular depolarizations) triggers in group 1 and Purkinje PVC ablation in group 2 were effective with no VF recurrence in 91 percent at 31 +/- 26 months follow-up. Single procedure success was 67 percent. Ablation resulted in the disappearance of the ER pattern in 82 percent.</p><p class="headingAnchor" id="H595044"><span class="h3">Acute treatment of ER syndrome with VF storm</span><span class="headingEndMark"> — </span>For patients with ER syndrome and ongoing acute VF requiring frequent defibrillation, we suggest intravenous <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a>  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>). In a multicenter observational cohort study of 122 patients (90 males, mean age 37±12 years) with ER in the inferolateral leads and more than three episodes of idiopathic VF (including those with electrical storm), isoproterenol was effective for the acute suppression of VF, immediately suppressing electrical storms in seven of seven patients [<a href="#rid101">101</a>]. <a class="drug drug_general" data-topicid="10281" href="/d/drug information/10281.html" rel="external">Theophylline</a> has been described in a case report as eliminating ongoing malignant ventricular arrhythmias in spite of treatment with <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a> and high-rate ventricular pacing [<a href="#rid102">102</a>]. High-dose <a class="drug drug_general" data-topicid="8449" href="/d/drug information/8449.html" rel="external">flecainide</a> has also been reported to be effective at suppressing VF in ER syndrome in a case report [<a href="#rid103">103</a>].</p><p>In an experimental canine model of ER, <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a>, <a class="drug drug_general" data-topicid="8872" href="/d/drug information/8872.html" rel="external">cilostazol</a>, and <a class="drug drug_general" data-topicid="9652" href="/d/drug information/9652.html" rel="external">milrinone</a>, each administered individually, have been shown to suppress hypothermia-induced ventricular arrhythmias [<a href="#rid104">104</a>]. Furthermore in an ER syndrome wedge preparation, cilostazol and milrinone or <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> were demonstrated to reverse the repolarization defects underlying the development of phase 2 reentry and VT/VF by inhibition of transient outward potassium current (Ito) and augmentation of L-type calcium current (Ica) [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H595085"><span class="h3">Chronic treatment of ER syndrome</span><span class="headingEndMark"> — </span>Chronic treatment of the ER syndrome should include an ICD for rapid treatment of any recurrent VF  (<a class="graphic graphic_table graphicRef93392" href="/d/graphic/93392.html" rel="external">table 1</a>) [<a href="#rid12">12,41</a>]. Patients with frequent recurrent episodes of VF resulting in ICD shocks may require suppressive therapy with an antiarrhythmic drug and, rarely, ablation of a stereotypic initiating PVC. (See  <a class="medical medical_review" href="/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ER syndrome with prior resuscitated SCD due to VF, we recommend implantation of an ICD for secondary prevention of SCD. ICD therapy is highly effective in terminating ventricular arrhythmias in nearly all cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antiarrhythmic drug therapy is a therapeutic option for patients with recurrent VF following ICD implantation. For patients with ER syndrome and recurrent VF, we suggest the use of <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a>, a class IA antiarrhythmic drug, for chronic suppressive therapy. Class IA antiarrhythmic drugs have been shown to prevent reinduction of polymorphic ventricular arrhythmias both during electrophysiologic (EP) study and in long-term follow-up in patients with idiopathic VF [<a href="#rid96">96,105</a>]. The target dose should be 800 to 1600 mg per day, with a common target of 1200 to 1600 mg of quinidine sulfate divided in four doses. (See  <a class="medical medical_review" href="/d/html/972.html" rel="external">"Pharmacologic therapy in survivors of sudden cardiac arrest"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ER syndrome and prior idiopathic VF but no documented recurrent arrhythmias, we do not suggest chronic suppressive treatment with an antiarrhythmic drug as the frequency of recurrent VF attributed to ER syndrome is highly variable and not readily predicted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an in vitro pharmacological model, the phosphodiesterase III inhibitors <a class="drug drug_general" data-topicid="8872" href="/d/drug information/8872.html" rel="external">cilostazol</a> or <a class="drug drug_general" data-topicid="9652" href="/d/drug information/9652.html" rel="external">milrinone</a> have been demonstrated to diminish ER manifestations and prevent the hypothermia-induced phase 2 reentry and ventricular tachycardia (VT)/VF [<a href="#rid104">104</a>]. <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">Quinidine</a> also demonstrated similar effects in this model.</p><p></p><p>Patients with ER syndrome who participate in competitive athletics require further evaluation and appropriate precautions prior to returning to competition [<a href="#rid106">106</a>].</p><p class="headingAnchor" id="H3156479377"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116416.html" rel="external">"Society guideline links: Inherited arrhythmia syndromes"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115586.html" rel="external">"Society guideline links: Ventricular arrhythmias"</a>.)</p><p class="headingAnchor" id="H24316993"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Early repolarization (ER) is defined as either a sharp well-defined positive deflection or notch immediately following a positive QRS complex at the onset of the ST segment, or the presence of slurring at the terminal part of the QRS complex (since the J-wave or J-point elevation may be hidden in the terminal part of the QRS complex, resulting in the slurring of the terminal QRS complex)  (<a class="graphic graphic_waveform graphicRef83883" href="/d/graphic/83883.html" rel="external">waveform 1</a>). Most literature defines ER as being present on the ECG when there is J-point elevation of ≥0.1 mV in two adjacent leads with either a slurred or notched morphology. (See <a class="local">'ECG findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ER is an ECG finding. Two terms, distinguished by the presence or absence of symptomatic arrhythmias, have been used to describe patients with this ECG finding (see <a class="local">'ER pattern versus ER syndrome'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The <strong>ER pattern</strong> describes the patient with appropriate ECG findings in the absence of symptomatic arrhythmias.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The <strong>ER syndrome</strong> applies to the patient with both appropriate ECG findings and symptomatic arrhythmias (cardiac arrest).</p><p></p><p class="bulletIndent1">The mere presence of ER pattern on ECG should not lead to a classification of ER syndrome in the absence of symptoms or documented ventricular fibrillation (VF).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several population studies have estimated that the prevalence of ER ranges from 5 to 13 percent of persons. The perception that ER was a benign finding has changed, with numerous studies suggesting a two- to threefold increased risk of death in those with ER versus those without ER. While ER appears to increase one's risk of sudden cardiac death (SCD), the absolute risk of SCD remains exceedingly low in otherwise healthy people. (See <a class="local">'Prevalence'</a> above and <a class="local">'Arrhythmic risk'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The genetic basis of ER continues to be elucidated, with the evidence restricted to either case reports or preliminary studies that fall short of clearly identifying the genetic basis of ER. (See <a class="local">'Genetic basis and inheritance of ER'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The purported mechanisms of ER and idiopathic VF reflect either an imbalance in the ion channel currents responsible for the terminal portion of depolarization or the early portion of repolarization and/or abnormal epicardial RV depolarization abnormalities with conduction delay. (See <a class="local">'Mechanism of ER and idiopathic ventricular fibrillation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Given its relatively high prevalence in the general population in comparison with the incidence of idiopathic VF, the ER pattern is almost always an incidental ECG finding. The diagnosis of ER syndrome, however, should be considered in a survivor of SCD with ECG evidence of ER and VF and an apparently structurally normal heart following extensive testing. (See <a class="local">'ER pattern'</a> above and <a class="local">'ER syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with the incidental finding of the ER pattern on their ECG, we recommend observation without therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_1" rel="external">Grade 1A</a>). (See <a class="local">'Treatment of ER pattern'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ER and ongoing acute VF (VF storm) requiring frequent defibrillation, we suggest intravenous <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Acute treatment of ER syndrome with VF storm'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ER syndrome with prior resuscitated SCD due to VF, we recommend implantation of an implantable cardioverter-defibrillator (ICD) for secondary prevention of SCD (<a class="grade" href="https://medilib.ir/uptodate/show/grade_1" rel="external">Grade 1A</a>). (See <a class="local">'Chronic treatment of ER syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ER syndrome and recurrent VF, we suggest the use of <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a>, a class IA antiarrhythmic drug, for chronic suppressive therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Chronic treatment of ER syndrome'</a> above.)</p><p></p><p class="bulletIndent1">Catheter ablation targeting epicardial substrates and/or Purkinje premature ventricular complex (PVC) triggers is appropriate in patients with recurrent VF not responding to <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a>. (See  <a class="medical medical_review" href="/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with ER syndrome who have had an ICD placed but who have had no documented recurrent arrhythmias do not require chronic antiarrhythmic drug treatment. (See <a class="local">'Chronic treatment of ER syndrome'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119:e241.</a></li><li><a class="nounderline abstract_t">Patton KK, Ellinor PT, Ezekowitz M, et al. Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. Circulation 2016; 133:1520.</a></li><li><a class="nounderline abstract_t">Macfarlane PW, Antzelevitch C, Haissaguerre M, et al. The Early Repolarization Pattern: A Consensus Paper. J Am Coll Cardiol 2015; 66:470.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008; 358:2016.</a></li><li><a class="nounderline abstract_t">Tikkanen JT, Anttonen O, Junttila MJ, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009; 361:2529.</a></li><li><a class="nounderline abstract_t">Antzelevitch C, Yan GX. J wave syndromes. Heart Rhythm 2010; 7:549.</a></li><li><a class="nounderline abstract_t">Antzelevitch C, Yan GX, Viskin S. Rationale for the use of the terms J-wave syndromes and early repolarization. J Am Coll Cardiol 2011; 57:1587.</a></li><li><a class="nounderline abstract_t">Nam GB, Ko KH, Kim J, et al. Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome. Eur Heart J 2010; 31:330.</a></li><li><a class="nounderline abstract_t">Surawicz B, Macfarlane PW. Inappropriate and confusing electrocardiographic terms: J-wave syndromes and early repolarization. J Am Coll Cardiol 2011; 57:1584.</a></li><li><a class="nounderline abstract_t">Wilde AA. "J-wave syndromes" bring the ATP-sensitive potassium channel back in the spotlight. Heart Rhythm 2012; 9:556.</a></li><li><a class="nounderline abstract_t">Derval N, Simpson CS, Birnie DH, et al. Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry. J Am Coll Cardiol 2011; 58:722.</a></li><li><a class="nounderline abstract_t">Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36:2793.</a></li><li><a class="nounderline abstract_t">Rosso R, Kogan E, Belhassen B, et al. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol 2008; 52:1231.</a></li><li><a class="nounderline abstract_t">Sinner MF, Reinhard W, Müller M, et al. Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med 2010; 7:e1000314.</a></li><li><a class="nounderline abstract_t">Haruta D, Matsuo K, Tsuneto A, et al. Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram. Circulation 2011; 123:2931.</a></li><li><a class="nounderline abstract_t">McNamara DA, Bennett AJ, Ayers C, et al. Early Repolarization Pattern Is Associated With Increased Left Ventricular Mass: Insights From the Dallas Heart Study. JACC Clin Electrophysiol 2019; 5:395.</a></li><li><a class="nounderline abstract_t">Olson KA, Viera AJ, Soliman EZ, et al. Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. Eur Heart J 2011; 32:3098.</a></li><li><a class="nounderline abstract_t">Abe A, Ikeda T, Tsukada T, et al. Circadian variation of late potentials in idiopathic ventricular fibrillation associated with J waves: insights into alternative pathophysiology and risk stratification. Heart Rhythm 2010; 7:675.</a></li><li><a class="nounderline abstract_t">Sugao M, Fujiki A, Nishida K, et al. Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol 2005; 45:545.</a></li><li><a class="nounderline abstract_t">Sahara M, Sagara K, Yamashita T, et al. J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome? Jpn Heart J 2002; 43:55.</a></li><li><a class="nounderline abstract_t">Kalla H, Yan GX, Marinchak R. Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant? J Cardiovasc Electrophysiol 2000; 11:95.</a></li><li><a class="nounderline abstract_t">Aizawa Y, Tamura M, Chinushi M, et al. Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block. Am Heart J 1993; 126:1473.</a></li><li><a class="nounderline abstract_t">Siebermair J, Sinner MF, Beckmann BM, et al. Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years. Europace 2016; 18:718.</a></li><li><a class="nounderline abstract_t">Rosso R, Glikson E, Belhassen B, et al. Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology. Heart Rhythm 2012; 9:225.</a></li><li><a class="nounderline abstract_t">Wu SH, Lin XX, Cheng YJ, et al. Early repolarization pattern and risk for arrhythmia death: a meta-analysis. J Am Coll Cardiol 2013; 61:645.</a></li><li><a class="nounderline abstract_t">Tikkanen JT, Junttila MJ, Anttonen O, et al. Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome. Circulation 2011; 123:2666.</a></li><li><a class="nounderline abstract_t">Serra-Grima R, Doñate M, Álvarez-García J, et al. Long-term follow-up of early repolarization pattern in elite athletes. Am J Med 2015; 128:192.e1.</a></li><li><a class="nounderline abstract_t">Barbosa EC, Bomfim Ade S, Benchimol-Barbosa PR, Ginefra P. Ionic mechanisms and vectorial model of early repolarization pattern in the surface electrocardiogram of the athlete. Ann Noninvasive Electrocardiol 2008; 13:301.</a></li><li><a class="nounderline abstract_t">Quattrini FM, Pelliccia A, Assorgi R, et al. Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes. Heart Rhythm 2014; 11:1974.</a></li><li><a class="nounderline abstract_t">Klatsky AL, Oehm R, Cooper RA, et al. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med 2003; 115:171.</a></li><li><a class="nounderline abstract_t">Rollin A, Maury P, Bongard V, et al. Prevalence, prognosis, and identification of the malignant form of early repolarization pattern in a population-based study. Am J Cardiol 2012; 110:1302.</a></li><li><a class="nounderline abstract_t">Ilkhanoff L, Soliman EZ, Prineas RJ, et al. Clinical characteristics and outcomes associated with the natural history of early repolarization in a young, biracial cohort followed to middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circ Arrhythm Electrophysiol 2014; 7:392.</a></li><li><a class="nounderline abstract_t">Cheng YJ, Lin XX, Ji CC, et al. Role of Early Repolarization Pattern in Increasing Risk of Death. J Am Heart Assoc 2016; 5.</a></li><li><a class="nounderline abstract_t">Pargaonkar VS, Perez MV, Jindal A, et al. Long-term prognosis of early repolarization with J-wave and QRS slur patterns on the resting electrocardiogram: a cohort study. Ann Intern Med 2015; 163:747.</a></li><li><a class="nounderline abstract_t">Roten L, Derval N, Maury P, et al. Benign vs. malignant inferolateral early repolarization: Focus on the T wave. Heart Rhythm 2016; 13:894.</a></li><li><a class="nounderline abstract_t">Yoon N, Hong SN, Cho JG, et al. Experimental verification of the value of the Tpeak -Tend interval in ventricular arrhythmia inducibility in an early repolarization syndrome model. J Cardiovasc Electrophysiol 2019; 30:2098.</a></li><li><a class="nounderline abstract_t">Karim Talib A, Sato N, Sakamoto N, et al. Enhanced transmural dispersion of repolarization in patients with J wave syndromes. J Cardiovasc Electrophysiol 2012; 23:1109.</a></li><li><a class="nounderline abstract_t">Cristoforetti Y, Biasco L, Giustetto C, et al. J-wave duration and slope as potential tools to discriminate between benign and malignant early repolarization. Heart Rhythm 2016; 13:806.</a></li><li><a class="nounderline abstract_t">Holkeri A, Eranti A, Haukilahti MAE, et al. Impact of age and sex on the long-term prognosis associated with early repolarization in the general population. Heart Rhythm 2020; 17:621.</a></li><li><a class="nounderline abstract_t">Nunn LM, Bhar-Amato J, Lowe MD, et al. Prevalence of J-point elevation in sudden arrhythmic death syndrome families. J Am Coll Cardiol 2011; 58:286.</a></li><li><a class="nounderline abstract_t">Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013; 10:1932.</a></li><li><a class="nounderline abstract_t">Merchant FM, Noseworthy PA, Weiner RB, et al. Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol 2009; 104:1402.</a></li><li><a class="nounderline abstract_t">Cheng YJ, Li ZY, Yao FJ, et al. Early repolarization is associated with a significantly increased risk of ventricular arrhythmias and sudden cardiac death in patients with structural heart diseases. Heart Rhythm 2017; 14:1157.</a></li><li><a class="nounderline abstract_t">Walsh JA 3rd, Ilkhanoff L, Soliman EZ, et al. Natural history of the early repolarization pattern in a biracial cohort: CARDIA (Coronary Artery Risk Development in Young Adults) Study. J Am Coll Cardiol 2013; 61:863.</a></li><li><a class="nounderline abstract_t">Perez MV, Uberoi A, Jain NA, et al. The prognostic value of early repolarization with ST-segment elevation in African Americans. Heart Rhythm 2012; 9:558.</a></li><li><a class="nounderline abstract_t">Rosso R, Adler A, Halkin A, Viskin S. Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective. Heart Rhythm 2011; 8:923.</a></li><li><a class="nounderline abstract_t">Patel RB, Ilkhanoff L, Ng J, et al. Clinical characteristics and prevalence of early repolarization associated with ventricular arrhythmias following acute ST-elevation myocardial infarction. Am J Cardiol 2012; 110:615.</a></li><li><a class="nounderline abstract_t">Patel RB, Ng J, Reddy V, et al. Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease. Circ Arrhythm Electrophysiol 2010; 3:489.</a></li><li><a class="nounderline abstract_t">Furukawa Y, Yamada T, Morita T, et al. Early repolarization pattern associated with sudden cardiac death: long-term follow-up in patients with chronic heart failure. J Cardiovasc Electrophysiol 2013; 24:632.</a></li><li><a class="nounderline abstract_t">Watanabe H, Makiyama T, Koyama T, et al. High prevalence of early repolarization in short QT syndrome. Heart Rhythm 2010; 7:647.</a></li><li><a class="nounderline abstract_t">Panicker GK, Manohar D, Karnad DR, et al. Early repolarization and short QT interval in healthy subjects. Heart Rhythm 2012; 9:1265.</a></li><li><a class="nounderline abstract_t">Caliskan K, Ujvari B, Bauernfeind T, et al. The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias. J Cardiovasc Electrophysiol 2012; 23:938.</a></li><li><a class="nounderline abstract_t">Laksman ZW, Gula LJ, Saklani P, et al. Early repolarization is associated with symptoms in patients with type 1 and type 2 long QT syndrome. Heart Rhythm 2014; 11:1632.</a></li><li><a class="nounderline abstract_t">Sugrue A, Rohatgi RK, Bos M, et al. Clinical Significance of Early Repolarization in Long QT Syndrome. JACC Clin Electrophysiol 2018; 4:1238.</a></li><li><a class="nounderline abstract_t">Tülümen E, Schulze-Bahr E, Zumhagen S, et al. Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia. Europace 2016; 18:1587.</a></li><li><a class="nounderline abstract_t">Kaneko Y, Horie M, Niwano S, et al. Electrical storm in patients with brugada syndrome is associated with early repolarization. Circ Arrhythm Electrophysiol 2014; 7:1122.</a></li><li><a class="nounderline abstract_t">Hasegawa Y, Watanabe H, Ikami Y, et al. Early repolarization and risk of lone atrial fibrillation. J Cardiovasc Electrophysiol 2019; 30:565.</a></li><li><a class="nounderline abstract_t">McNair PW, Benenson DM, Ip JE, et al. Prevalence of early repolarization pattern in patients with lone atrial fibrillation. J Electrocardiol 2017; 50:545.</a></li><li><a class="nounderline abstract_t">Mahida S, Derval N, Sacher F, et al. Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. J Am Coll Cardiol 2015; 65:151.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Chatel S, Sacher F, et al. Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol 2009; 20:93.</a></li><li><a class="nounderline abstract_t">Watanabe H, Nogami A, Ohkubo K, et al. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol 2011; 4:874.</a></li><li><a class="nounderline abstract_t">Medeiros-Domingo A, Tan BH, Crotti L, et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm 2010; 7:1466.</a></li><li><a class="nounderline abstract_t">Barajas-Martínez H, Hu D, Ferrer T, et al. Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm 2012; 9:548.</a></li><li><a class="nounderline abstract_t">Burashnikov E, Pfeiffer R, Barajas-Martinez H, et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010; 7:1872.</a></li><li><a class="nounderline abstract_t">Noseworthy PA, Tikkanen JT, Porthan K, et al. The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol 2011; 57:2284.</a></li><li><a class="nounderline abstract_t">Reinhard W, Kaess BM, Debiec R, et al. Heritability of early repolarization: a population-based study. Circ Cardiovasc Genet 2011; 4:134.</a></li><li><a class="nounderline abstract_t">Gourraud JB, Le Scouarnec S, Sacher F, et al. Identification of large families in early repolarization syndrome. J Am Coll Cardiol 2013; 61:164.</a></li><li><a class="nounderline abstract_t">Patocskai B, Barajas-Martinez H, Hu D, et al. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. Heart Rhythm 2016; 13:1326.</a></li><li><a class="nounderline abstract_t">Ji CC, Yao FJ, Cheng YJ, et al. A novel DPP6 variant in Chinese families causes early repolarization syndrome. Exp Cell Res 2019; 384:111561.</a></li><li><a class="nounderline abstract_t">Cheng YJ, Yao H, Ji CC, et al. A Heterozygous Missense hERG Mutation Associated with Early Repolarization Syndrome. Cell Physiol Biochem 2018; 51:1301.</a></li><li><a class="nounderline abstract_t">Takayama K, Ohno S, Ding WG, et al. A de novo gain-of-function KCND3 mutation in early repolarization syndrome. Heart Rhythm 2019; 16:1698.</a></li><li><a class="nounderline abstract_t">Teumer A, Trenkwalder T, Kessler T, et al. KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern. JCI Insight 2019; 4.</a></li><li><a class="nounderline abstract_t">Chauveau S, Janin A, Till M, et al. Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing. HeartRhythm Case Rep 2017; 3:574.</a></li><li><a class="nounderline abstract_t">Li N, Wang R, Hou C, et al. A heterozygous missense SCN5A mutation associated with early repolarization syndrome. Int J Mol Med 2013; 32:661.</a></li><li><a class="nounderline abstract_t">Yao H, Ji CC, Cheng YJ, et al. Mutation in KCNE1 associated to early repolarization syndrome by modulation of slowly activating delayed rectifier K+ current. Exp Cell Res 2018; 363:315.</a></li><li><a class="nounderline abstract_t">Sinner MF, Porthan K, Noseworthy PA, et al. A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. Heart Rhythm 2012; 9:1627.</a></li><li><a class="nounderline abstract_t">Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996; 93:372.</a></li><li><a class="nounderline abstract_t">Nademanee K, Haissaguerre M, Hocini M, et al. Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome. Circulation 2019; 140:1477.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Nademanee K, Hocini M, et al. Depolarization versus repolarization abnormality underlying inferolateral J-wave syndromes: New concepts in sudden cardiac death with apparently normal hearts. Heart Rhythm 2019; 16:781.</a></li><li><a class="nounderline abstract_t">Voskoboinik A, Hsia H, Moss J, et al. The many faces of early repolarization syndrome: A single-center case series. Heart Rhythm 2020; 17:273.</a></li><li><a class="nounderline abstract_t">Koncz I, Gurabi Z, Patocskai B, et al. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome. J Mol Cell Cardiol 2014; 68:20.</a></li><li><a class="nounderline abstract_t">Roten L, Derval N, Sacher F, et al. Heterogeneous response of J-wave syndromes to beta-adrenergic stimulation. Heart Rhythm 2012; 9:1970.</a></li><li><a class="nounderline abstract_t">Maury P, Sacher F, Rollin A, et al. Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome. Europace 2012; 14:148.</a></li><li><a class="nounderline abstract_t">Krahn AD, Healey JS, Chauhan V, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009; 120:278.</a></li><li><a class="nounderline abstract_t">Aizawa Y, Chinushi M, Hasegawa K, et al. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol 2013; 62:1015.</a></li><li><a class="nounderline abstract_t">Mizumaki K, Nishida K, Iwamoto J, et al. Vagal activity modulates spontaneous augmentation of J-wave elevation in patients with idiopathic ventricular fibrillation. Heart Rhythm 2012; 9:249.</a></li><li><a class="nounderline abstract_t">Letsas KP, Sacher F, Probst V, et al. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome. Heart Rhythm 2008; 5:1685.</a></li><li><a class="nounderline abstract_t">Sarkozy A, Chierchia GB, Paparella G, et al. Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 2:154.</a></li><li><a class="nounderline abstract_t">Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007; 115:442.</a></li><li><a class="nounderline abstract_t">Hong K, Berruezo-Sanchez A, Poungvarin N, et al. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol 2004; 15:64.</a></li><li><a class="nounderline abstract_t">Kawata H, Noda T, Yamada Y, et al. Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome. Heart Rhythm 2012; 9:77.</a></li><li><a class="nounderline abstract_t">Nam GB, Kim YH, Antzelevitch C. Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med 2008; 358:2078.</a></li><li><a class="nounderline abstract_t">Roten L, Derval N, Sacher F, et al. Ajmaline attenuates electrocardiogram characteristics of inferolateral early repolarization. Heart Rhythm 2012; 9:232.</a></li><li><a class="nounderline abstract_t">Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011; 123:1270.</a></li><li><a class="nounderline abstract_t">Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018; 72:e91.</a></li><li><a class="nounderline abstract_t">Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990; 120:661.</a></li><li><a class="nounderline abstract_t">Wever EF, Hauer RN, Oomen A, et al. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993; 88:1021.</a></li><li><a class="nounderline abstract_t">Marcus FI. Idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997; 8:1075.</a></li><li><a class="nounderline abstract_t">Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation 1997; 95:265.</a></li><li><a class="nounderline abstract_t">Meissner MD, Lehmann MH, Steinman RT, et al. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 1993; 21:1406.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 2009; 53:612.</a></li><li><a class="nounderline abstract_t">Perrin T, Guieu R, Koutbi L, et al. Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization. Pacing Clin Electrophysiol 2018; 41:444.</a></li><li><a class="nounderline abstract_t">Ahn J, Roh SY, Lee DI, et al. Effect of flecainide on suppression of ventricular fibrillation in a patient with early repolarization syndrome. Heart Rhythm 2016; 13:1724.</a></li><li><a class="nounderline abstract_t">Gurabi Z, Koncz I, Patocskai B, et al. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. Circ Arrhythm Electrophysiol 2014; 7:134.</a></li><li><a class="nounderline abstract_t">Belhassen B, Viskin S, Fish R, et al. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10:1301.</a></li><li><a class="nounderline abstract_t">Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66:2424.</a></li></ol></div><div id="topicVersionRevision">Topic 83199 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19228821" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27067089" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26205599" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Early Repolarization Pattern: A Consensus Paper.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18463377" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sudden cardiac arrest associated with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19917913" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Long-term outcome associated with early repolarization on electrocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20153265" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : J wave syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21474038" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Rationale for the use of the terms J-wave syndromes and early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19880418" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21474037" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Inappropriate and confusing electrocardiographic terms: J-wave syndromes and early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22227635" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : "J-wave syndromes" bring the ATP-sensitive potassium channel back in the spotlight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21816308" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320108" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18926326" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20668657" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21646495" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30898244" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Early Repolarization Pattern Is Associated With Increased Left Ventricular Mass: Insights From the Dallas Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21785106" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20189495" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Circadian variation of late potentials in idiopathic ventricular fibrillation associated with J waves: insights into alternative pathophysiology and risk stratification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15897781" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12041890" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10695469" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8249808" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26759124" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21914497" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23290543" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Early repolarization pattern and risk for arrhythmia death: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21632493" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24979742" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Long-term follow-up of early repolarization pattern in elite athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18713332" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Ionic mechanisms and vectorial model of early repolarization pattern in the surface electrocardiogram of the athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25092400" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12935822" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The early repolarization normal variant electrocardiogram: correlates and consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22819431" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prevalence, prognosis, and identification of the malignant form of early repolarization pattern in a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24759868" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical characteristics and outcomes associated with the natural history of early repolarization in a young, biracial cohort followed to middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27671315" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Role of Early Repolarization Pattern in Increasing Risk of Death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26501238" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Long-term prognosis of early repolarization with J-wave and QRS slur patterns on the resting electrocardiogram: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26592849" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Benign vs. malignant inferolateral early repolarization: Focus on the T wave.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31424133" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Experimental verification of the value of the Tpeak -Tend interval in ventricular arrhythmia inducibility in an early repolarization syndrome model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22612896" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Enhanced transmural dispersion of repolarization in patients with J wave syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26601769" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : J-wave duration and slope as potential tools to discriminate between benign and malignant early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31683018" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Impact of age and sex on the long-term prognosis associated with early repolarization in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21737021" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prevalence of J-point elevation in sudden arrhythmic death syndrome families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011539" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19892058" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28416467" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Early repolarization is associated with a significantly increased risk of ventricular arrhythmias and sudden cardiac death in patients with structural heart diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23428218" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Natural history of the early repolarization pattern in a biracial cohort: CARDIA (Coronary Artery Risk Development in Young Adults) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22094072" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The prognostic value of early repolarization with ST-segment elevation in African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21295159" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22658503" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Clinical characteristics and prevalence of early repolarization associated with ventricular arrhythmias following acute ST-elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20657030" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23397903" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Early repolarization pattern associated with sudden cardiac death: long-term follow-up in patients with chronic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20206319" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : High prevalence of early repolarization in short QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22449739" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Early repolarization and short QT interval in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22587370" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24861447" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Early repolarization is associated with symptoms in patients with type 1 and type 2 long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30236400" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Clinical Significance of Early Repolarization in Long QT Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26705564" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25221333" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Electrical storm in patients with brugada syndrome is associated with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30661277" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Early repolarization and risk of lone atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28511782" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prevalence of early repolarization pattern in patients with lone atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25593056" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19120683" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22028457" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558321" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22056721" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20817017" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21600720" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The early repolarization pattern in the general population: clinical correlates and heritability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21282333" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Heritability of early repolarization: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23273290" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Identification of large families in early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26820510" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31476289" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : A novel DPP6 variant in Chinese families causes early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30481776" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A Heterozygous Missense hERG Mutation Associated with Early Repolarization Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31173922" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A de novo gain-of-function KCND3 mutation in early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31600170" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29296579" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23799537" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A heterozygous missense SCN5A mutation associated with early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29395134" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Mutation in KCNE1 associated to early repolarization syndrome by modulation of slowly activating delayed rectifier K+ current.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22683750" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8548912" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Cellular basis for the electrocardiographic J wave.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31542949" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30391571" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Depolarization versus repolarization abnormality underlying inferolateral J-wave syndromes: New concepts in sudden cardiac death with apparently normal hearts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31521808" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The many faces of early repolarization syndrome: A single-center case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24378566" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22864265" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Heterogeneous response of J-wave syndromes to beta-adrenergic stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21846638" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597050" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23747791" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21939630" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Vagal activity modulates spontaneous augmentation of J-wave elevation in patients with idiopathic ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19084806" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19808460" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17224476" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15028074" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21855521" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18463391" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Augmentation of J waves and electrical storms in patients with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21914496" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Ajmaline attenuates electrocardiogram characteristics of inferolateral early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21403098" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29097296" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2202193" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Idiopathic ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8353864" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9300306" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Idiopathic ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8994445" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8473649" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19215837" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29148059" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27033341" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Effect of flecainide on suppression of ventricular fibrillation in a patient with early repolarization syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24429494" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10515552" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26542662" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
